2ME2 Effectively Treats and Prevents Metastatic Breast Cancer

2ME2, or 2-methoxyestradiol, is an exciting anti-breast cancer drug now in clinical trials. This drug can prevent the spread of breast cancer cells to your bones, and bone destruction (osteolysis) from cancer, and targets tumors very effectively. 2ME2 has been tested on sarcoma, lung and brain cancers; and in some cases, caused the cancer cells to self-destruct. "We were expecting the drug to have an effect, but we were not expecting to have as big of an effect as it did," said Urszula Iwaniec, an assistant professor in the Department of Nutrition and Exercise Sciences at Oregon State University and a coauthor of the study on 2ME2.

• Drug Found Effective In Treating, Preventing Breast Cancer
• Breast Cancer Definition, Types, Symptoms